Avelox Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Eradication of H. Pylori Infection With Moxifloxacin
Conditions:   Helicobacter Pylori Infection;   Helicobacter Pylori Infection, Susceptibility to Interventions:   Drug: Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID;   Drug: Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID Sponsor:   Iyad Naeem Muhammad, PhD Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials